- Report
- April 2025
- 145 Pages
Global
From €2686EUR$2,999USD£2,290GBP
- Report
- April 2025
- 175 Pages
Global
From €4022EUR$4,490USD£3,428GBP
- Report
- May 2025
- 187 Pages
Global
From €3175EUR$3,545USD£2,707GBP
€3528EUR$3,939USD£3,008GBP
- Report
- December 2022
- 130 Pages
Global
From €5329EUR$5,950USD£4,543GBP
- Report
- January 2024
- 200 Pages
Global
From €3717EUR$4,150USD£3,169GBP
- Report
- January 2022
- 292 Pages
Global
From €3224EUR$3,600USD£2,749GBP
The Single Cell Multiomics market is a subset of the larger Genomics market. It focuses on the analysis of single cells, which can provide a more detailed understanding of the biological processes within a cell. This market is driven by the need to understand the complexity of biological systems, as well as the development of new technologies that enable the analysis of single cells.
Single Cell Multiomics technologies are used to analyze the transcriptome, epigenome, proteome, and metabolome of single cells. This allows researchers to gain a better understanding of the molecular mechanisms that underlie cellular processes. Additionally, Single Cell Multiomics can be used to identify biomarkers and to develop new therapeutic strategies.
Some companies in the Single Cell Multiomics market include 10x Genomics, Fluidigm, Bio-Rad, Illumina, and Thermo Fisher Scientific. Show Less Read more
